Back to News
Oct 31, 2025 4:00 PM

Earnings Preview For TG Therapeutics

TG Therapeutics (NASDAQ:TGTX) will release its quarterly earnings report on Monday, 2025-11-03. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate TG Therapeutics to report an earnings per share (EPS) of $0.22.

The announcement from TG Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings Track Record

The company's EPS missed by $0.13 in the last quarter, leading to a 1.11% drop in the share price on the following day.

Here's a look at TG Therapeutics's past performance and the resulting price change:

Quarter

Q2 2025

Q1 2025

Q4 2024

Q3 2024

EPS Estimate

0.30

0.17

0.08

0.03

EPS Actual

0.17

0.03

0.15

0.02

Price Change %

-1.00

-7.00

3.00

6.00

Stock Performance

Shares of TG Therapeutics were trading at $34.02 as of October 30. Over the last 52-week period, shares are up 44.95%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

Analyst Observations about TG Therapeutics

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on TG Therapeutics.

Analysts have provided TG Therapeutics with 2 ratings, resulting in ...